{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:41:21Z","timestamp":1794440481430,"version":"4.9.1"},"reference-count":110,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Brain metastases (BM) from lung cancer remain a devastating complication that severely compromises patient survival. Its development is driven by dynamic and complex interactions between tumor cells and the central nervous system microenvironment, involving blood-brain barrier disruption, immunosuppressive niche formation, neural co-optation, metabolic adaptation, and peripheral immune dysregulation. Current strategies face intrinsic resistance and delivery barriers. This review aimed to systematically examine these mechanisms and therapeutic frontiers, including emerging interventions that preserve vascular-neural integrity, intercept neurotransmitter-mediated tumor support, reprogram brain resident cells, exploit metabolic vulnerabilities, and engineer advanced delivery systems, thereby proposing directions to overcome therapeutic challenges in lung cancer BM.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1763830","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:08:32Z","timestamp":1777442912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The immune microenvironment of the central nervous system and neuromodulation: new perspectives in lung cancer brain metastases research"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaoyu","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine","place":["Shanghai, China"]},{"name":"Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxing","family":"Huo","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine","place":["Shanghai, China"]},{"name":"Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine","place":["Shanghai, China"]},{"name":"Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqi","family":"Xiong","sequence":"additional","affiliation":[{"name":"Center for Excellence in Brain Science and Intelligence Technology, Institute of Neuroscience and State Key Laboratory of Neuroscience, Chinese Academy of Sciences","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialiang","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine","place":["Shanghai, China"]},{"name":"Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine","place":["Shanghai, China"]},{"name":"Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35242","article-title":"Cumulative incidence and risk factors of brain metastases in metastatic non-small cell lung cancer without baseline brain metastasis: Pooled analysis of individualized patient data from IMpower130, IMpower131, and IMpower150","volume":"130","author":"Zhou","year":"2024","journal-title":"Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112152-20240510-00189","article-title":"Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer for patients (2024 edition)","volume":"34","year":"2024","journal-title":"Chin J Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-025-00848-1","article-title":"Metabolic adaptations of brain metastasis","volume":"25","author":"Parida","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35350","article-title":"Immunotherapy for metastatic non-small cell lung cancer: Is it really a no-brainer","volume":"130","author":"Young","year":"2024","journal-title":"Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3892\/ijo.2022.5390","article-title":"Differences in actionable genomic alterations between brain metastases and non-brain metastases in patients with non-small cell lung cancer","volume":"61","author":"Nian","year":"2022","journal-title":"Int J Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-24-784","article-title":"Single-cell and spatial transcriptomics reveal a potential role of ATF3 in brain metastasis of lung adenocarcinoma","volume":"14","author":"Xu","year":"2025","journal-title":"Transl Lung Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.canrad.2019.10.001","article-title":"Meta-analysis of prophylactic cranial irradiation or not in treatment of extensive-stage small-cell lung cancer: The dilemma remains","volume":"24","author":"Wen","year":"2020","journal-title":"Cancer Radiother"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.11735\/j.issn.1671-170X.2024.03.B001","article-title":"Progress on immunotherapy combined with chemotherapy, radiotherapy and targeted therapy for brain metastasis of small cell lung cancer","volume":"30","author":"Que","year":"2024","journal-title":"J Chin Oncolog"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32030171","article-title":"Immunotherapy and the tumor microenvironment in brain metastases from non-small cell lung cancer: Challenges and future directions","volume":"32","author":"Wang","year":"2025","journal-title":"Curr Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-025-00916-6","article-title":"Blood-brain barrier alterations as an initiator of brain metastasis from lung cancer: A new take on an old story","volume":"32","author":"Wu","year":"2025","journal-title":"Cancer Gene Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189320","article-title":"Biological mechanisms and immunotherapy of brain metastases in non-small cell lung cancer","volume":"1880","author":"Jiang","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217870","article-title":"Targeting the cholinergic-astrocyte axis: A novel strategy for brain metastasis prevention in lung adenocarcinoma","volume":"628","author":"Li","year":"2025","journal-title":"Cancer Lett"},{"key":"B14","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41419-021-04004-z","article-title":"TGF-\u03b21-mediated exosomal lnc-MMP2-2 increases blood-brain barrier permeability via the miRNA-1207-5p\/EPB41L5 axis to promote non-small cell lung cancer brain metastasis","volume":"12","author":"Wu","year":"2021","journal-title":"Cell Death Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.825899","article-title":"Exosomal lncRNA LINC01356 derived from brain metastatic nonsmall-cell lung cancer cells remodels the blood-brain barrier","volume":"12","author":"Geng","year":"2022","journal-title":"Front Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.18632\/aging.202324","article-title":"HOXB9 enhances the ability of lung cancer cells to penetrate the blood-brain barrier","volume":"13","author":"Zheng","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114199","article-title":"MicroRNA-522-3p promotes brain metastasis in non-small cell lung cancer by targeting Tensin 1 and modulating blood-brain barrier permeability","volume":"442","author":"Liu","year":"2024","journal-title":"Exp Cell Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"590","DOI":"10.52586\/4969","article-title":"The role of astrocytes in brain metastasis at the interface of circulating tumour cells and the blood brain barrier","volume":"26","author":"Burn","year":"2021","journal-title":"FBL"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16241","article-title":"Multifaceted interactions between cancer cells and glial cells in brain metastasis","volume":"115","author":"Ishibashi","year":"2024","journal-title":"Cancer Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1221097","article-title":"Immunotherapy and brain metastasis in lung cancer: Connecting bench side science to the clinic","volume":"14","author":"Rios-Hoyo","year":"2023","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3779\/j.issn.1009-3419.2016.09.12","article-title":"Tumor cells and micro-environment in brain metastases","volume":"19","author":"Zhong","year":"2016","journal-title":"Cancer Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41392-022-00872-9","article-title":"Targeting polarized phenotype of microglia via IL6\/JAK2\/STAT3 signaling to reduce NSCLC brain metastasis","volume":"7","author":"Jin","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216146","article-title":"Extracellular vesicle-derived LINC00482 induces microglial M2 polarization to facilitate brain metastasis of NSCLC","volume":"561","author":"Xu","year":"2023","journal-title":"Cancer Lett"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e20191131","DOI":"10.1084\/jem.20191131","article-title":"Nicotine promotes brain metastasis by polarizing microglia and suppressing innate immune function","volume":"217","author":"Wu","year":"2020","journal-title":"J Exp Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/advs.73843","article-title":"Cholesterol promotes lung adenocarcinoma brain metastasis by stabilizing EGFR protein to drive EMT, metabolic reprogramming, and premetastatic niche formation","volume":"13","author":"Chen","year":"2026","journal-title":"Adv Sci (Weinh)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2025.04.009","article-title":"Microglia transcriptional states and their functional significance: Context drives diversity","volume":"58","author":"Depp","year":"2025","journal-title":"Immunity"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.109187","article-title":"SEC61G facilitates brain metastases via antagonizing PGAM1 ubiquitination and immune microenvironment remodeling in non-small cell lung cancer","volume":"21","author":"Zhou","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2119\/2006\u201300033.He","article-title":"Differential reactions of microglia to brain metastasis of lung cancer","volume":"12","author":"He","year":"2006","journal-title":"Mol Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101533","article-title":"Targeting the HSP47-collagen axis inhibits brain metastasis by reversing M2 microglial polarization and restoring anti-tumor immunity","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13046-024-03024-9","article-title":"Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization","volume":"43","author":"Liu","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s10555-025-10276-0","article-title":"Astrocyte involvement in brain metastasis: From biological mechanisms to therapeutic strategies","volume":"44","author":"Zhou","year":"2025","journal-title":"Cancer Metastasis Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nature18268","article-title":"Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer","volume":"533","author":"Chen","year":"2016","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10585-010-9354-8","article-title":"Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis","volume":"28","author":"Seike","year":"2011","journal-title":"Clin Exp Metastasis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41392-025-02514-2","article-title":"Lipocalin-2 drives brain metastatic progression through reciprocal tumor-microenvironment interactions in lung cancer","volume":"10","author":"Zhu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306348","article-title":"Brain metastasis from EGFR-mutated non-small cell lung cancer: Secretion of IL11 from astrocytes up-regulates PDL1 and promotes immune escape","volume":"11","author":"Tang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13046-025-03315-9","article-title":"GABA regulates metabolic reprogramming to mediate the development of brain metastasis in non-small cell lung cancer","volume":"44","author":"Xie","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.devcel.2024.01.010","article-title":"Astrocyte-induced mGluR1 activates human lung cancer brain metastasis via glutamate-dependent stabilization of EGFR","volume":"59","author":"Ishibashi","year":"2024","journal-title":"Dev Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-16-1978","article-title":"Extracellular matrix receptor expression in subtypes of lung adenocarcinoma potentiates outgrowth of micrometastases","volume":"77","author":"Stevens","year":"2017","journal-title":"Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.01.040","article-title":"Serpins promote cancer cell survival and vascular co-option in brain metastasis","volume":"156","author":"Valiente","year":"2014","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/s12575-023-00192-4","article-title":"Influence of exosomes on astrocytes in the pre-metastatic niche of lung cancer brain metastases","volume":"25","author":"Ye","year":"2023","journal-title":"Biol Proced Online"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.829451","article-title":"Tumor immune microenvironment and immunotherapy in brain metastasis from non-small cell lung cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14473","article-title":"An integrated biomarker of PD-L1 expression and intraepithelial CD8(+) T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection of brain metastases","volume":"13","author":"Li","year":"2022","journal-title":"Thorac Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz207","article-title":"Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer","volume":"30","author":"Kudo","year":"2019","journal-title":"Ann Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1038\/s41598-018-20622-8","article-title":"Contraction of T cell richness in lung cancer brain metastases","volume":"8","author":"Mansfield","year":"2018","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1038\/s41467-026-70715-6","article-title":"Identification of altered immune landscape at single-cell resolution in NSCLC brain metastasis and its association with poor immune checkpoint inhibitor responses","volume":"17","author":"Bai","year":"2026","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.781150","article-title":"NFAT as a biomarker and therapeutic target in non\u2013small cell lung cancer\u2013related brain metastasis","volume":"11","author":"Peng","year":"2021","journal-title":"Front Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03530-z","article-title":"Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases","volume":"31","author":"Tagore","year":"2025","journal-title":"Nat Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41421-025-00828-7","article-title":"Immunological and pathological characteristics of brain parenchymal and leptomeningeal metastases from non-small cell lung cancer","volume":"11","author":"Zhou","year":"2025","journal-title":"Cell Discov"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000002088","article-title":"Single-cell map of diverse\u00a0immune phenotypes in the metastatic brain tumor microenvironment of\u00a0nonsmall-cell lung cancer","volume":"111","author":"Wang","year":"2025","journal-title":"Int J Surg"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab290","article-title":"Neuronal exposure induces neurotransmitter signaling and synaptic mediators in tumors early in brain metastasis","volume":"24","author":"Deshpande","year":"2021","journal-title":"Neuro-Oncology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09492-z","article-title":"Neuronal activity-dependent mechanisms of small cell lung cancer pathogenesis","volume":"646","author":"Savchuk","year":"2025","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09434-9","article-title":"Functional synapses between neurons and small cell lung cancer","volume":"646","author":"Sakthivelu","year":"2025","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2024.12.049","article-title":"Exploring the cellular and molecular basis of nerve growth factor in cerebral ischemia recovery","volume":"566","author":"Gu","year":"2025","journal-title":"Neuroscience"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.3390\/cancers13122891","article-title":"The emerging role of amino acids of the brain microenvironment in the process of metastasis formation","volume":"13","author":"Cutruzzol\u00e0","year":"2021","journal-title":"Cancers"},{"key":"B55","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12987-018-0113-6","article-title":"Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier","volume":"15","author":"Hladky","year":"2018","journal-title":"Fluids Barriers CNS"},{"key":"B56","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13073-024-01410-8","article-title":"Integrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis reveal the metabolic vulnerability as a novel therapeutic target","volume":"16","author":"Duan","year":"2024","journal-title":"Genome Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41419-025-08006-z","article-title":"The IGF2BP3-FASN axis drives lipid metabolic reprogramming to promote brain colonization in non-small cell lung cancer","volume":"16","author":"Li","year":"2025","journal-title":"Cell Death Dis"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1177\/10732748221076805","article-title":"Relationship between lymphocyte to monocyte ratio and brain metastasis in non-smalll cell lung cancer patients","volume":"14","author":"Liu","year":"2022","journal-title":"Am J Transl Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0423","article-title":"Prognostic value of lymphocyte-to-monocyte ratio and systemic immune-inflammation index in non-small-cell lung cancer patients with brain metastases","volume":"16","author":"Li","year":"2020","journal-title":"Future Oncol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1582788","article-title":"Complete blood count parameters as potential predictive factors of brain metastases in lung cancer","volume":"15","author":"Marschollek","year":"2025","journal-title":"Front Oncol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1092721","article-title":"Risk factors and a new nomogram for predicting brain metastasis from lung cancer: a retrospective study","volume":"13","author":"Wu","year":"2023","journal-title":"Front Oncol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1554242","article-title":"Developing a predictive model and uncovering immune influences on prognosis for brain metastasis from lung carcinomas","volume":"15","author":"Wang","year":"2025","journal-title":"Front Oncol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-019-02384-y","article-title":"Tumor-induced peripheral immunosuppression promotes brain metastasis in patients with non-small cell lung cancer","volume":"68","author":"Li","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.e21215","article-title":"Association of IDO immune suppression with brain metastasis in non-small cell lung cancer","volume":"39","author":"Chen","year":"2021","journal-title":"J Clin Oncol"},{"key":"B65","first-page":"2024.04.10.588829","article-title":"NSCLC patients with oligo-metastatic brain disease show an altered CD4 T-cells immune profile","volume-title":"bioRxiv","author":"Alsousli","year":"2024"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-023-04512-2","article-title":"Treatment and survival of patients with small cell lung cancer and brain metastasis","volume":"165","author":"Chiang","year":"2023","journal-title":"J Neuro-Oncol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-14-2082","article-title":"Bevacizumab in patients with nonsquamous non-small cell lung cancer and asymptomatic, untreated brain metastases (BRAIN): a nonrandomized, phase II study","volume":"21","author":"Besse","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1000-484X.2022.14.023","article-title":"Progress of targeted therapy and immunotherapy for brain metastasis of nonsmall cell lung cancer","volume":"38","author":"Zhang","year":"2022","journal-title":"Chin J Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N Engl J Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612674","article-title":"Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer","volume":"376","author":"Mok","year":"2017","journal-title":"N Engl J Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-019-00637-5","article-title":"Efficacy of crizotinib for advanced ALK-rearranged non-small-cell lung cancer patients with brain metastasis: a multicenter, retrospective study in China","volume":"14","author":"Xing","year":"2019","journal-title":"Target Oncol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"100513","DOI":"10.1016\/j.medj.2024.09.002","article-title":"First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: the phase 3 EVEREST trial","volume":"6","author":"Zhou","year":"2025","journal-title":"Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2025.1779","article-title":"High-dose aumolertinib for untreated EGFR-variant non\u2013small cell lung cancer with brain metastases: the ACHIEVE phase 2 nonrandomized clinical trial","volume":"11","author":"Li","year":"2025","journal-title":"JAMA Oncol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2306434","article-title":"Osimertinib with or without chemotherapy in EGFR-mutated advanced NSCLC","volume":"389","author":"Planchard","year":"2023","journal-title":"N Engl J Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10585-019-10008-z","article-title":"Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model","volume":"37","author":"Masuda","year":"2020","journal-title":"Clin Exp Metastasis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s13402-026-01181-x","article-title":"Strategies to target PD-1\/PD-L1 in the tumor microenvironment","volume":"49","author":"Kui","year":"2026","journal-title":"Cell Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2021.100205","article-title":"Outcomes with pembrolizumab monotherapy in patients with programmed death-ligand 1-positive NSCLC with brain metastases: pooled analysis of KEYNOTE-001, 010, 024, and 042","volume":"2","author":"Mansfield","year":"2021","journal-title":"JTO Clin Res Rep"},{"key":"B78","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.annonc.2023.10.117","article-title":"Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study","volume":"35","author":"Passaro","year":"2024","journal-title":"Ann Oncol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jtho.2021.09.010","article-title":"First-line nivolumab plus ipilimumab in advanced NSCLC: 4-year outcomes from the randomized, open-label, phase 3 CheckMate 227 part 1 trial","volume":"17","author":"Paz-Ares","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/cm9.0000000000003055","article-title":"Expert consensus on immunotherapy for small cell lung cancer (2025 edition)","volume":"1","year":"2025","journal-title":"J Chin Oncolog"},{"key":"B81","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/s1470-2045(24)00643-0","article-title":"Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial","volume":"26","author":"Xu","year":"2025","journal-title":"Lancet Oncol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.cell.2017.02.025","article-title":"Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis","volume":"168","author":"Boire","year":"2017","journal-title":"Cell"},{"key":"B83","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ccell.2023.12.018","article-title":"Interrogation of endothelial and mural cells in brain metastasis reveals key immune-regulatory mechanisms","volume":"42","author":"Bejarano","year":"2024","journal-title":"Cancer Cell"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaf027","article-title":"Tumor cells upregulate neurotransmitter GABA in the choroid plexus through STAT6-Bestrophin1 signaling, promoting leptomeningeal dissemination","volume":"27","author":"Das","year":"2025","journal-title":"Neuro-Oncology"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022111112","article-title":"Immune surveillance of brain metastatic cancer cells is mediated by IFITM1","volume":"42","author":"She","year":"2023","journal-title":"EMBO J"},{"key":"B86","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/ph14060559","article-title":"Lung cancer management with silibinin: a historical and translational perspective","volume":"14","author":"Verdura","year":"2021","journal-title":"Pharm (Basel)"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.7150\/thno.122241","article-title":"CD146(+) pericyte-like lung cancer brain metastatic stem cells promote tumor angiogenesis through dual regulatory effects on the VEGF\/VEGFR axis","volume":"16","author":"Liu","year":"2026","journal-title":"Theranostics"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz2193","article-title":"Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis","volume":"369","author":"Chi","year":"2020","journal-title":"Science"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202508478","article-title":"Neutrophil extracellular trap reprograms cancer metabolism to form a metastatic niche promoting non-small cell lung cancer brain metastasis","volume":"13","author":"Chen","year":"2026","journal-title":"Adv Sci (Weinh)"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2025.07.129","article-title":"Final analysis results and patient-reported outcomes from DESTINY-Lung02-A dose-blinded, randomized, phase 2 study of trastuzumab deruxtecan in patients with HER2-mutant metastatic NSCLC","volume":"20","author":"J\u00e4nne","year":"2025","journal-title":"J Thorac Oncol"},{"key":"B91","first-page":"1319MO","volume-title":"Intracranial efficacy of HER3-DXd in patients with previously treated advanced EGFR-mutated NSCLC: results from HERTHENA-Lung01","author":"Janne","year":"2023"},{"key":"B92","first-page":"Abstract OA10.01","volume-title":"Intracranial efficacy of datopotamab deruxtecan (Dato-DXd) in patients with advanced\/metastatic NSCLC in TROPION-Lung01","author":"Pons-Tostivint","year":"2025"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1516419","article-title":"Antibody-drug conjugates in cancer therapy: applications and future advances","volume":"16","author":"Long","year":"2025","journal-title":"Front Immunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12645-021-00084-w","article-title":"Lipid polymeric nanoparticles modified with tight junction-modulating peptides promote afatinib delivery across a blood\u2013brain barrier model","volume":"12","author":"Lo","year":"2021","journal-title":"Cancer Nanotechnol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12951-024-02414-7","article-title":"Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases","volume":"22","author":"Jiang","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c09996","article-title":"Carcinoma\u2013astrocyte gap junction interruption by a dual-targeted biomimetic liposomal system to attenuate chemoresistance and treat brain metastasis","volume":"18","author":"Cheng","year":"2024","journal-title":"ACS Nano"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.7150\/thno.47137","article-title":"USP7 targeting modulates anti-tumor immune response by reprogramming tumor-associated macrophages in lung cancer","volume":"10","author":"Dai","year":"2020","journal-title":"Theranostics"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70020","article-title":"Metastatic brain tumors: from development to cutting-edge treatment","volume":"6","author":"Tanzhu","year":"2025","journal-title":"MedComm (2020)"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.89","article-title":"Synthetic immune niches for cancer immunotherapy","volume":"18","author":"Weiden","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2910892","article-title":"The value of the systemic immune-inflammation index in predicting survival outcomes in patients with brain metastases of non-small-cell lung cancer treated with stereotactic radiotherapy","volume":"2021","author":"Zhang","year":"2021","journal-title":"Mediators Inflammation"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/brain\/85.1.1","article-title":"Clinico-EEG study of 128 gliomas and 50 intracranial metastatic tumours","volume":"85","author":"Fisher-Williams","year":"1962","journal-title":"Brain"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaa034","article-title":"Multidisciplinary patient-centered management of brain metastases and future directions","volume":"2","author":"Palmer","year":"2020","journal-title":"Neuro-Oncol Adv"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2024.102623","article-title":"Factors associated with perceived cognitive function in breast cancer patients treated with chemotherapy: a multicenter cross-sectional study","volume":"71","author":"Liu","year":"2024","journal-title":"Eur J Oncol Nurs"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2025.11.007","article-title":"The evolving landscape of brain metastasis: volume II","volume":"12","author":"Valiente","year":"2025","journal-title":"Trends Cancer"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-10028-8","article-title":"Tumour-brain crosstalk restrains cancer immunity via a sensory-sympathetic axis","volume":"650","author":"Wei","year":"2026","journal-title":"Nature"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-025-01110-4","article-title":"Microphysiological systems for metastasis research: a stepwise approach","volume":"48","author":"Sharko","year":"2025","journal-title":"Cell Oncol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2025.08.003","article-title":"Cancer neuroscience of brain metastasis: When in Rome, do as the Romans do","volume":"113","author":"Karreman","year":"2025","journal-title":"Neuron"},{"key":"B108","doi-asserted-by":"publisher","first-page":"e006243","DOI":"10.1136\/jitc-2022-006243","article-title":"Heterogeneity of tumor immune microenvironment of EGFR\/ALK-positive tumors versus EGFR\/ALK-negative tumors in resected brain metastases from lung adenocarcinoma","volume":"11","author":"Xiao","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412590","article-title":"Predicting survival rates in brain metastases patients from non-small cell lung cancer using radiomic signatures associated with tumor immune heterogeneity","volume":"12","author":"Deng","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.91295","article-title":"Radiotherapy in preclinical models of brain metastases: a review and recommendations for future studies","volume":"20","author":"Shi","year":"2024","journal-title":"Int J Biol Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1763830\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:08:37Z","timestamp":1777442917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1763830\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":110,"alternative-id":["10.3389\/fimmu.2026.1763830"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1763830","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"article-number":"1763830"}}